Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

542 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Randomized comparison of the stanford V regimen and ABVD in the treatment of advanced Hodgkin's Lymphoma: United Kingdom National Cancer Research Institute Lymphoma Group Study ISRCTN 64141244.
Hoskin PJ, Lowry L, Horwich A, Jack A, Mead B, Hancock BW, Smith P, Qian W, Patrick P, Popova B, Pettitt A, Cunningham D, Pettengell R, Sweetenham J, Linch D, Johnson PW. Hoskin PJ, et al. Among authors: horwich a. J Clin Oncol. 2009 Nov 10;27(32):5390-6. doi: 10.1200/JCO.2009.23.3239. Epub 2009 Sep 8. J Clin Oncol. 2009. PMID: 19738111 Clinical Trial.
Breast cancer risk after supradiaphragmatic radiotherapy for Hodgkin's lymphoma in England and Wales: a National Cohort Study.
Swerdlow AJ, Cooke R, Bates A, Cunningham D, Falk SJ, Gilson D, Hancock BW, Harris SJ, Horwich A, Hoskin PJ, Linch DC, Lister TA, Lucraft HH, Radford JA, Stevens AM, Syndikus I, Williams MV. Swerdlow AJ, et al. Among authors: horwich a. J Clin Oncol. 2012 Aug 1;30(22):2745-52. doi: 10.1200/JCO.2011.38.8835. Epub 2012 Jun 25. J Clin Oncol. 2012. PMID: 22734026
Risk of premature menopause after treatment for Hodgkin's lymphoma.
Swerdlow AJ, Cooke R, Bates A, Cunningham D, Falk SJ, Gilson D, Hancock BW, Harris SJ, Horwich A, Hoskin PJ, Linch DC, Lister A, Lucraft HH, Radford J, Stevens AM, Syndikus I, Williams MV; England and Wales Hodgkin Lymphoma Follow-up Group. Swerdlow AJ, et al. Among authors: horwich a. J Natl Cancer Inst. 2014 Aug 19;106(9):dju207. doi: 10.1093/jnci/dju207. Print 2014 Sep. J Natl Cancer Inst. 2014. PMID: 25139687
Lymphocyte-predominant Hodgkin's lymphoma.
Horwich A, Cunningham D. Horwich A, et al. J Clin Oncol. 2010 Jul 1;28(19):e325; author reply e326. doi: 10.1200/JCO.2010.28.4893. Epub 2010 Jun 1. J Clin Oncol. 2010. PMID: 20516449 No abstract available.
GEM-P chemotherapy is active in the treatment of relapsed Hodgkin lymphoma.
Hawkes EA, Barton S, Cunningham D, Peckitt C, Chua S, Wotherspoon A, Horwich A, Potter M, Ethel M, Dearden C, Chau I. Hawkes EA, et al. Among authors: horwich a. Ann Hematol. 2014 May;93(5):827-34. doi: 10.1007/s00277-013-1930-y. Epub 2013 Oct 26. Ann Hematol. 2014. PMID: 24158386
Bleomycin and scuba diving: where is the harm?
de Wit R, Sleijfer S, Kaye SB, Horwich A, Mead B, Sleijfer DT, Stoter G. de Wit R, et al. Among authors: horwich a. Lancet Oncol. 2007 Nov;8(11):954-5. doi: 10.1016/S1470-2045(07)70321-2. Lancet Oncol. 2007. PMID: 17976605 No abstract available.
Randomized trial of 30 versus 20 Gy in the adjuvant treatment of stage I Testicular Seminoma: a report on Medical Research Council Trial TE18, European Organisation for the Research and Treatment of Cancer Trial 30942 (ISRCTN18525328).
Jones WG, Fossa SD, Mead GM, Roberts JT, Sokal M, Horwich A, Stenning SP. Jones WG, et al. Among authors: horwich a. J Clin Oncol. 2005 Feb 20;23(6):1200-8. doi: 10.1200/JCO.2005.08.003. J Clin Oncol. 2005. PMID: 15718317 Clinical Trial.
542 results